Clinical behaviours and prognoses of high- and low-risk parotid malignancies based on histology
- PMID: 30506411
- DOI: 10.1007/s00405-018-5224-9
Clinical behaviours and prognoses of high- and low-risk parotid malignancies based on histology
Abstract
Purpose: To report 5-year survival in patients with primary parotid malignant tumours and assess the impact of various factors on survival or local control among diverse histologic groups.
Methods: A total of 65 patients with primary parotid malignant tumours who had surgery between 2003 and 2014 were identified. Demographic characteristics including age, T stage, N stage and clinical or pathological performance were analysed. According to risk stratification (based on pathology), 65 primary parotid malignant tumours were divided into high-risk (23, 35.38%) and low-risk (35, 53.85%) groups. Overall survival (OS) and disease-free survival (DFS) were recorded by the Kaplan-Meier methods.
Results: The 5-year overall survival rate for primary parotid malignant tumours was 70.9%. Patients older than 60 years with fixed mass, pain, facial-nerve palsy and high-grade N stage had adverse OS and DFS. Upon multivariable analysis, facial-nerve palsy (HR 24.59; 95% CI 2.338-178.446; P = 0.002) was the only independent predictive factor for OS. Patients with high-risk parotid malignant types were more likely to have tumour pain, facial-nerve palsy (Chi-square test: < 0.0001 and 0.02), lymphatic metastasis and local/regional recurrence (Chi-square test: 0.008 and 0.012).
Conclusions: Compared with low-risk parotid carcinoma, tumours with high-risk histological features tend to need aggressive surgical extirpation, neck dissection and postoperative radiotherapy.
Keywords: Disease-free survival (DFS); Overall survival (OS); Primary parotid malignant tumour; Prognosis; Risk stratification.
Comment in
-
Letter to the Editor regarding "Clinical behaviors and prognoses of high- and low-risk parotid malignancies based on histology" by Tao L. et al.Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2625. doi: 10.1007/s00405-019-05412-w. Epub 2019 Mar 29. Eur Arch Otorhinolaryngol. 2019. PMID: 30927101 No abstract available.
-
The author's reply regarding "Clinical Behaviours and Prognoses of High and Low Risk Parotid Malignancies Based on Histology".Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2627. doi: 10.1007/s00405-019-05551-0. Epub 2019 Jul 18. Eur Arch Otorhinolaryngol. 2019. PMID: 31321503 No abstract available.
Similar articles
-
The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.Am J Clin Oncol. 2017 Jun;40(3):323-328. doi: 10.1097/COC.0000000000000157. Am J Clin Oncol. 2017. PMID: 25503431
-
Parotid salivary duct carcinoma: a single institution's 20-year experience.Eur Arch Otorhinolaryngol. 2019 Jul;276(7):2031-2038. doi: 10.1007/s00405-019-05454-0. Epub 2019 May 6. Eur Arch Otorhinolaryngol. 2019. PMID: 31062093 Free PMC article.
-
Oncological outcome and prognostic factors in malignant parotid tumours.J Craniomaxillofac Surg. 2014 Jan;42(1):59-65. doi: 10.1016/j.jcms.2013.02.003. Epub 2013 Mar 29. J Craniomaxillofac Surg. 2014. PMID: 23541937
-
Malignant tumours of the parotid gland: management of the neck (including the clinically negative neck) and a literature review.Br J Oral Maxillofac Surg. 2021 Jul;59(6):665-671. doi: 10.1016/j.bjoms.2020.08.026. Epub 2020 Aug 27. Br J Oral Maxillofac Surg. 2021. PMID: 33952405 Review.
-
Salivary duct carcinoma: clinical characteristics and treatment strategies.Head Neck. 1997 Mar;19(2):126-33. doi: 10.1002/(sici)1097-0347(199703)19:2<126::aid-hed7>3.0.co;2-6. Head Neck. 1997. PMID: 9059870 Review.
Cited by
-
Establishment and Validation of Prognostic Nomograms for Patients With Parotid Gland Adenocarcinoma Not Otherwise Specified: A SEER Analysis From 2004 to 2016.Front Surg. 2022 Jan 11;8:799452. doi: 10.3389/fsurg.2021.799452. eCollection 2021. Front Surg. 2022. PMID: 35087861 Free PMC article.
-
Letter to the Editor regarding "Clinical behaviors and prognoses of high- and low-risk parotid malignancies based on histology" by Tao L. et al.Eur Arch Otorhinolaryngol. 2019 Sep;276(9):2625. doi: 10.1007/s00405-019-05412-w. Epub 2019 Mar 29. Eur Arch Otorhinolaryngol. 2019. PMID: 30927101 No abstract available.
-
Impact of Changing Surgical Strategies on Clinical Outcomes in Patients with Parotid Carcinoma: A 53-Year Single-Institution Experience.Medicina (Kaunas). 2021 Jul 23;57(8):745. doi: 10.3390/medicina57080745. Medicina (Kaunas). 2021. PMID: 34440951 Free PMC article.
-
[Application of free peroneal artery chimeric perforator flap in repairing the defect after advanced local lesions resection in parotid gland carcinoma].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022 Jan 15;36(1):79-85. doi: 10.7507/1002-1892.202106117. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2022. PMID: 35038803 Free PMC article. Chinese.
References
MeSH terms
Grants and funding
- 81772878/Major Research Plan
- SHDC12015114/the Science and Technology Innovation Project of Shanghai Shen-kang Hospital Clinical Development Center
- 16411950100/Science and Technology Commission of Shanghai Municipality
- 09QA1401000/the Shanghai Science and Technology Development Funds
- 10QA1405900/the Shanghai Science and Technology Development Funds
- 14411961900/the Shanghai Science and Technology Development Funds
- XYQ2011055/the Training Program of the Excellent Young Talents of Shanghai Municipal Health System
- XYQ2011015/the Training Program of the Excellent Young Talents of Shanghai Municipal Health System
- 11JC1410802/the Shanghai Municipal Science and Technology Foundation
LinkOut - more resources
Full Text Sources